GSK PLC SP. ADR/2 NEW Net Asset Momentum
GSK PLC SP. ADR/2 NEW net asset momentum. GSK PLC SP. ADR/2 NEW (GS70) recorded a net asset momentum of 21.9% as of December 2025, with net assets of €15.96 Billion EUR. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. Explore GS70 capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
YoY Momentum
Current Net Assets
Years of Data
Country
Net Asset Momentum of GSK PLC SP. ADR/2 NEW (2021–2025)
Net asset momentum of GSK PLC SP. ADR/2 NEW from 2021 to 2025. This chart tracks GSK PLC SP. ADR/2 NEW's year-over-year net asset growth across 5 annual reporting periods from 2021 to 2025. The most recent momentum reading is +21.9%, with net assets of €15.96 Billion EUR as of December 2025. See GSK PLC SP. ADR/2 NEW shareholders equity for net asset value and shareholders' equity analysis.
GSK PLC SP. ADR/2 NEW Net Asset Momentum by Year (2021–2025)
GSK PLC SP. ADR/2 NEW net asset momentum by year from 2021 to 2025. The table below shows the complete annual net asset history for GSK PLC SP. ADR/2 NEW from 2021 to 2025, covering 5 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and overall valuation, see GSK PLC SP. ADR/2 NEW market cap and net worth.
| Year | Net Assets (EUR) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | €15.96 Billion | €61.12 Billion | €45.16 Billion | ▲ +21.9% |
| 2024 | €13.09 Billion | €59.46 Billion | €46.38 Billion | ▲ +2.3% |
| 2023 | €12.79 Billion | €59.01 Billion | €46.21 Billion | ▲ +26.7% |
| 2022 | €10.10 Billion | €60.15 Billion | €50.05 Billion | ▼ -52.7% |
| 2021 | €21.34 Billion | €79.10 Billion | €57.76 Billion | — |